Classic Hodgkin lymphoma post-transplant lymphoproliferative disorders (PTLD) are often preceded by discordant PTLD subtypes

References

• Shannon-Lowe C, Rickinson AB, Bell AI. Epstein-Barr virus-associated lymphomas. Philos Trans R Soc Lond B Biol Sci. 2017;372(1732):20160271.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues (revised 4th Ed.). Lyon: IARC; 2017.
   Google Scholar
• Jones K, Wockner L, Thornton A, et al. HLA class I associations with EBV + post-transplant lymphoproliferative disorder. Trans Immunol. 2015;32(2):126–130.
   PubMed Web of Science ®Google Scholar
• Hjalgrim H, Rostgaard K, Johnson PCD, et al. HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma. Proc Natl Acad Sci USA. 2010;107(14):6400–6405.
   PubMed Web of Science ®Google Scholar
• Niens M, Jarrett RF, Hepkema B, et al. HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV + Hodgkin lymphoma. Blood. 2007;110(9):3310–3315.
   PubMed Web of Science ®Google Scholar
• Huang X, Kushekhar K, Nolte I, et al. HLA associations in classical Hodgkin lymphoma: EBV status matters. PLOS One. 2012;7(7):e399986.
   Web of Science ®Google Scholar
• Forbes JF, Morris PJ. Analysis of HLA-A antigens in patients with Hodgkin's disease and their families. J Clin Invest. 1972;51(5):1156–1163.
   PubMed Web of Science ®Google Scholar
• Yin CC, Medeiros LJ, Abruzzo LV, et al. EBV-Associated B- and T-cell posttransplant lymphoproliferative disorders following primary EBV infection in a kidney transplant recipient. Am J Clin Pathol. 2005;123(2):222–228.
   PubMed Web of Science ®Google Scholar
• Lones M, Mishalani S, Shintaku IP, et al. Changes in tonsils and adenoids in children with posttransplant lymphoproliferative disorder: report of three cases with early involvement of Waldeyers ring. Hum Pathol. 1995;26(5):525–530.
   PubMed Web of Science ®Google Scholar
• La Fortune K, Zhang D, Raca G, et al. A unique "composite" PTLD with diffuse large B-cell and T/anaplastic large cell lymphoma components occurring 17 years after transplant. Case Rep Hematol. 2013;2013:386147.
   PubMedGoogle Scholar
• Kobayashi M, Asano N, Fukushima M, et al. Three different histological subtypes of Epstein-Barr virus-negative post-transplant lymphoproliferative disorder in a patient with hepatitis C infection. Int J Hematol. 2014;100(3):307–311.
   PubMed Web of Science ®Google Scholar
• Wu T, Swerdlow SH, Locker J, et al. Recurrent Epstein-Barr virus-associated lesions in organ transplant recipients. Hum Pathol. 1996;27(2):157–164.
   PubMed Web of Science ®Google Scholar
• Gheorghe G, Albano EA, Porter CC, et al. Posttransplant Hodgkin lymphoma preceded by polymorphic posttransplant lymphoproliferative disorder: report of a pediatric case and review of the literature. J Pediatr Hematol Oncol. 2007;29(2):112–116.
   PubMed Web of Science ®Google Scholar
• Dharnidharka VR, Douglas VK, Hunger SP, et al. Hodgkin's lymphoma after post-transplant lymphoproliferative disease in a renal transplant recipient. Pediatr Transplant. 2004;8(1):87–90.
   PubMed Web of Science ®Google Scholar
• Goyal RK, McEvoy L, Wilson DB. Hodgkin disease after renal transplantation in childhood. J Pediat Hematol-Oncol. 1996;18(4):392–395.
   PubMed Web of Science ®Google Scholar
• Ranganathan S, Webber S, Ahuja S, et al. Hodgkin-like posttransplant lymphoproliferative disorder in children: does it differ from posttransplant Hodgkin lymphoma? Pediatr Dev. Pathol. 2004;7(4):348–360.
   PubMed Web of Science ®Google Scholar
• Peters AC, Akinwumi MS, Cervera C, et al. The changing epidemiology of posttransplant lymphoproliferative disorder in adult solid organ transplant recipients over 30 years: a single-center experience. Transplantation. 2018;102(9):1553–1562.
   PubMed Web of Science ®Google Scholar
• Thorley-Lawson D. EBV persistence-introducing the virus. Curr Top Microbiol Immunol. 2015;390(Pt 1):151–209.
   PubMed Web of Science ®Google Scholar
• Stubbins RJ, Alami Laroussi N, Peters AC, et al. Epstein-Barr virus associated smooth muscle tumors in solid organ transplant recipients: incidence over 31 years at a single institution and review of the literature. Transpl Infect Dis. 2019;21(1):e13010.
   PubMed Web of Science ®Google Scholar
• Lokare A, Chaganti S, Lipkin G, et al. Posttransplant lymphoproliferative disorder followed by Hodgkins disease in a renal transplant recipient. Transplantation. 2008;85(8):1219–1220.
   PubMed Web of Science ®Google Scholar
• Novoa-Takara L, Dincer A, Kampalath B, et al. Post-transplant lymphoproliferative disorder with Hodgkin's lymphoma and large B-cell lymphoma differentiation. Histopathology. 2005;47(3):333–334.
   PubMed Web of Science ®Google Scholar
• Kampers J, Orjuela-Grimm M, Schober T, et al. Classical Hodgkin lymphoma-type PTLD after solid organ transplantation in children: a report on 17 patients treated according to subsequent GPOH-HD treatment schedules. Leuk Lymphoma. 2017;58(3):633–638.
   PubMed Web of Science ®Google Scholar
• Rosenberg AS, Klein AK, Ruthazer R, et al. Hodgkin lymphoma post-transplant lymphoproliferative disorder: a comparative analysis of clinical characteristics, prognosis, and survival. Am J Hematol. 2016;91(6):560–565.
   PubMed Web of Science ®Google Scholar
• Pitman SD, Huang Q, Zuppan CW, et al. Hodgkin lymphoma-like posttransplant lymphoproliferative disorder (HL-like PTLD) simulates monomorphic B-cell PTLD both clinically and pathologically. Am J Surg Pathol. 2006;30(4):470–476.
   PubMed Web of Science ®Google Scholar
• Adams H, Campidelli C, Dirnhofer S, et al. Clinical, phenotypic and genetic similarities and disparities between post-transplant and classical Hodgkin lymphomas with respect to therapeutic targets. Expert Opin Ther Targets. 2009;13(10):1137–1145.
   PubMed Web of Science ®Google Scholar
• Swerdlow S, Campo E, Harris NL, et al. WHO Classification ot tumors of the hematopoieitic and lymphoid tissues. IARC: Lyon. 2008.
   Google Scholar
• Quinlan SC, Landgren O, Morton LM, et al. Hodgkin lymphoma among US solid organ transplant recipients. Transplantation. 2010;90(9):1011–1015.
   PubMed Web of Science ®Google Scholar
• Caillard S, Lamy FX, Quelen C, for the French Transplant Centers, et al. Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the French registry and analysis of subgroups of lymphomas. Am J Transplant. 2012;12(3):682–693.
   PubMed Web of Science ®Google Scholar
• Bingler MA, Feingold B, Miller SA, et al. Chronic high Epstein-Barr viral load state and risk fore late-onset posttransplant lymphoproliferative disease/lymphoma in children. Am. J. Transplant. 2008;8(2):442–445.
   PubMed Web of Science ®Google Scholar
• Lau AH, Soltys K, Sindhi RK, et al. Chronic high Epstein-Barr viral load carriage in pediatric small bowel transplant recipients. Pediatr Transplant. 2010;14(4):549–553.
   PubMed Web of Science ®Google Scholar
• Hocker B, Bohm S, Fickenscher H, et al. Val-)Ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantation. Transpl Int. 2012;25(7):723–731.
   PubMed Web of Science ®Google Scholar
• Moran J, Carr M, Waters A, et al. Epstein-barr virus gene expression, human leukocyte antigen alleles and chronic high viral loads in pediatric renal transplant patients. Transplantation. 2011;92(3):328–333.
   Google Scholar
• Das B, Morrow R, Huang R, et al. Persistent Epstein-Barr viral load in Epstein-Barr viral naive pediatric heart transplant recipients: risk of late-onset post-transplant lymphoproliferative disease. WJT. 2016;6(4):729–735.
   Google Scholar
• Gotoh K, Ito Y, Ohta R, et al. Immunologic and virologic analyses in pediatric liver transplant recipients with chronic high Epstein-Barr virus loads. J Infect Dis. 2010;202(3):461–469.
   PubMed Web of Science ®Google Scholar
• Kullberg-Lindh C, Saalman R, Olausson M, et al. Epstein-Barr virus DNA monitoring in serum and whole blood in pediatric liver transplant recipients who do or do not discontinue immunosuppressive therapy. Pediatr Transplant. 2017;21(5):e.12875.
   Web of Science ®Google Scholar
• Tanaka E, Sato T, Ishihara M, et al. Asymptomatic high Epstein-Barr viral load carriage in pediatric renal transplant recipients. Pediatr Transplant. 2011;15(3):306–313.
   PubMed Web of Science ®Google Scholar
• Yamada M, Nguyen C, Fadakar P, et al. Epidemiology and outcome of chronic high Epstein-Barr viral load carriage in pediatric kidney transplant recipients. Pediatr Transplantation. 2018;22(3):e13147.
   PubMed Web of Science ®Google Scholar
• de Jong D, Roemer MG, Chan JK, et al. B-cell and classical Hodgkin lymphomas associated with immunodeficiency: 2015 SH/EAHP workshop report-part 2. Am J Clin Pathol. 2017;147(2):153–170.
   PubMed Web of Science ®Google Scholar
• Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science. 2011;331(6024):1565–1570.
   PubMed Web of Science ®Google Scholar
• Martin-Subero JI, Klapper W, Sotnikova A, Deutsche Krebshilfe Network Project Molecular Mechanisms in Malignant Lymphomas, et al. Chromosomal breakpoints affecting immunoglobulin loci are recurrent in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma. Cancer Res. 2006;66(21):10332–10338.
   PubMed Web of Science ®Google Scholar
• Murray PG, Young LS. An etiological role for the Epstein-Barr virus in the pathogenesis of classical Hodgkin lymphoma. Blood. 2019;134(7):591–596.
   PubMed Web of Science ®Google Scholar
• Fhu CW, Graham AM, Yap CT, et al. Reed-Sternberg cell-derived lymphotoxin-α activates endothelial cells to enhance T-cell recruitment in classical Hodgkin lymphoma. Blood. 2014;124(19):2973–2982.
   PubMed Web of Science ®Google Scholar
• Greaves P, Clear A, Owen A, et al. Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells. Blood. 2013;122(16):2856–2863.
   PubMed Web of Science ®Google Scholar
• Cattaruzza L, Gloghini A, Olivo K, et al. Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: Involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma. Int J Cancer. 2009;125(5):1092–1101.
   PubMed Web of Science ®Google Scholar
• Rickinson AB. Co-infections, inflammation and oncogenesis: future directions for EBV research. Semin Cancer Biol. 2014;26:99–115.
   PubMed Web of Science ®Google Scholar
• Lanoy E, Rosenberg PS, Fily F, et al. HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy. Blood. 2011;118(1):44–49.
   PubMed Web of Science ®Google Scholar
• Webber SA, Naftel DC, Fricker FJ, Pediatric Heart Transplant Study, et al. Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study. Lancet. 2006;367(9506):233–239.
   PubMed Web of Science ®Google Scholar
• Nelson BP, Wolniak KL, Evens A, et al. Early posttransplant lymphoproliferative disease: clinicopathologic features and correlation with mTOR signaling pathway activation. Am J Clin Pathol. 2012;138(4):568–578.
   PubMed Web of Science ®Google Scholar
• Quinlan SC, Pfeiffer RM, Morton LM, et al. Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States. Am J Hematol. 2011;86(2):206–209.
   PubMed Web of Science ®Google Scholar
• Moser E, Noordijk EM, van Leeuwen FE, et al. Risk of second cancer after treatment of aggressive non-Hodgkin’s lymphoma; an EORTC cohort study. Haematologica. 2006;91:1481–1488.
   PubMed Web of Science ®Google Scholar
• Rueffer U, Josting A, Franklin J, German Hodgkin's Lymphoma Study Group, et al. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis. J Clin Oncol. 2001;19(7):2026–2032.
   PubMed Web of Science ®Google Scholar
• Wang HW, Balakrishna JP, Pittaluga S, et al. Diagnosis of Hodgkin lymphoma in the modern era. Br J Haematol. 2019;184(1):45–59.
   PubMed Web of Science ®Google Scholar
• Hjalgrim H, Rostgaard K, Johnson PC, et al. HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma. PNAS. 2010;107(14):6400–6405.
   PubMed Web of Science ®Google Scholar
• Kinch A, Sundström C, Tufveson G, et al. Association between HLA-A1 and -A2 types and Epstein-Barr virus status of post-transplant lymphoproliferative disorder. Leuk Lymphoma. 2016;57(10):2351–2358.
   PubMed Web of Science ®Google Scholar
• Jones K, Wockner L, Brennan RM, et al. The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma. Clin Exp Immunol. 2016;183(2):206–220.
   PubMed Web of Science ®Google Scholar